US2013028884A1PendingUtilityA1

Composition and method for treatment of bruising

Assignee: SCARGUARD LABS LLCPriority: Nov 18, 2008Filed: Oct 9, 2012Published: Jan 31, 2013
Est. expiryNov 18, 2028(~2.3 yrs left)· nominal 20-yr term from priority
Inventors:Joel R. Studin
A61P 29/00A61K 9/006A61P 17/16A61K 9/0014A61K 36/28A61P 17/00A61K 38/4873A61K 36/15A61K 45/06
46
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

There is provided a skin treatment composition for oral or topical administration and a method for skin treatment. The composition comprises a chelating agent and at least one protease. The composition helps to remove hemosiderin that causes staining of skin on a bruised area and reduces inflammation and pain.

Claims

exact text as granted — not AI-modified
1 . (canceled) 
     
     
         2 . (canceled) 
     
     
         3 . (canceled) 
     
     
         4 . (canceled) 
     
     
         5 . A skin treatment composition, in the form of a kit comprising a chelating agent in an effective amount to remove hemosiderin from the body and reduce the staining of a bruised area of the skin, at least one protease and  Arnica Montana  extract as a separate oral dosage form. 
     
     
         6 . The skin treatment composition of  claim 5 , wherein the chelating agent is phytic acid. 
     
     
         7 . The skin treatment composition of  claim 5 , wherein the protease is bromelain. 
     
     
         8 . The skin treatment composition of  claim 5 , further comprising at least one of rutin, zinc, pine tree extract, vitamin K, vitamin C, vitamin E or coenzyme Q10. 
     
     
         9 . The skin treatment composition of  claim 8  comprising: about 25-75 mg phytic acid, about 150-300 mg bromelain, about 50-100 mg rutin, about 2-3 mg zinc, about 30-40 mg pine tree bark extract, about 10-15 mcg vitamin K, about 100-150 mg vitamin C, about 30-40 IU vitamin E, and about 5-15 mg coenzyme Q10. 
     
     
         10 . The skin treatment composition of  claim 9 , comprising about 30 c  Arnica montana  extract. 
     
     
         11 . The skin treatment composition of  claim 10 , comprising about 1 M  Arnica montana  extract. 
     
     
         12 . (canceled) 
     
     
         13 . The skin treatment composition of  claim 5 , wherein said  Arnica montana  extract is in a sublingual dosage form. 
     
     
         14 . The skin treatment composition of  claim 13 , wherein said chelating agent and protease are combined in a single swallowable dosage form. 
     
     
         15 . (canceled) 
     
     
         16 . (canceled) 
     
     
         17 . (canceled) 
     
     
         18 . (canceled) 
     
     
         19 . (canceled) 
     
     
         20 . (canceled) 
     
     
         21 . A method of skin treatment comprising oral administration of a composition comprising a chelating agent, at least one protease and a separate oral administration of  Arnica montana  extract.

Join the waitlist — get patent alerts

Track US2013028884A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.